期刊文献+

早产儿肠外营养相关性肝病的诊断与治疗 被引量:10

Diagnosis and therapeutic strategies of parenteral nutrition-associated liver disease in premature infants
原文传递
导出
摘要 早产儿肠外营养相关性肝病是早产儿长期胃肠外营养最主要的并发症之一,其主要特征是结合胆红素≥34.2 μmol/L,伴或不伴肝酶异常,排除其他疾病。其常见危险因素包括胎龄、低出生体质量、胃肠外营养的持续时间、胃肠外营养成分、感染、胃肠疾病、基因易感性等。这种肝损害大多程度较轻,停止静脉营养会自愈,但也有少数会进展到肝纤维化。尽管熊去氧胆酸和鱼油来源的、富含ω-3 PUFA(n-6∶n-3=1∶7)的脂肪乳剂可用于治疗肠外营养相关性肝病,但临床实际仍缺乏有效的预防、治疗肠外营养相关性肝病的策略,需不断寻找新的治疗手段。 Parenteral nutrition-associated liver disease (PNALD) or cholestasis (PNAC)is the main complication of prolonged parenteral nutrition in premature infants.It is characterized by cholestatic jaundice, which is defined as direct serum bilirubin of ≥34.2 μmol/L with or without liver enzymes abnormalities, rule out other causes.The risk factors contributing to the incidence of PNALD are premature, low birth weight, the duration of parenteral nutrition(PN), components of PN, sepsis, intestinal disease, genetic susceptibility.Although the damage is frequently mild, and resolves after discontinuation of parenteral nutrition, in some cases it progresses into cirrhotic changes.Ursodeoxycholic acid and lipid emulsions based on fish oil with a high content of long-chain polyunsaturated fatty acids ω-3 has been proposed to be efficacy.But effective preventive and therapeutic strategies for PNALD have not been established yet.Innovative therapeutic strategies needs to be investigated.
作者 胡玉莲 胡长霞 Hu Yulian;Hu Changxia(Department of Neonatology,Hubei Maternity and Child Health Hospital,Wuhan 430070,China)
出处 《中华实用儿科临床杂志》 CSCD 北大核心 2018年第19期1454-1459,共6页 Chinese Journal of Applied Clinical Pediatrics
关键词 婴儿 早产 肠外营养相关性肝病 熊去氧胆酸 脂肪乳剂 Premature infants Parenteral nutrition-associated liver disease Ursodeoxycholic acid Lipid emulsion
作者简介 通信作者:胡玉莲,Email:huyulian999@163.com
  • 相关文献

参考文献2

二级参考文献24

  • 1江少虎.思美泰与利胆醇治疗新生儿肝内胆汁淤积症的临床疗效观察[J].中国现代药物应用,2007,1(1):25-26. 被引量:9
  • 2李卉,冯琪,王颖,郭在晨.极低出生体重儿肠道外营养相关性胆汁淤积的临床研究[J].新生儿科杂志,2005,20(2):57-61. 被引量:49
  • 3张红珊,苏浩彬,麦友刚,吴燕云,赖文玉,欧阳颖,李文益.胃肠道外营养对早产儿肝胆功能的影响[J].中国当代儿科杂志,2005,7(5):432-434. 被引量:8
  • 4Guglielmi FW, Regano N, Mazzuoli S, Fregnan S, Leogrande G, Gulielmi A, et al. Cholestasis induced by total parenteral nutrition [J]. Clin Liver Dis, 2008, 12(1) :97-110.
  • 5A. S. P. E. N. Board of Directors and the clinical guidelines task force. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients [ J ]. JPEN J Parenter Enteral Nutr, 2002, 26 (Suppl) : 38SA-41SA.
  • 6Chen CY, Chen HL. The risk factors of parenteral nutrition-asso- ciated cholestasis in preterm infants [ J ]. Pediatr Neonatal, 2009, 50(5) :181-183.
  • 7Willis TC, Carter BA, Rogers SP, Hawthorne KM, Hicks PD, Abrams SA. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis [ J]. JPEN J Paren- ter Emeral Nutr, 2010, 34( 1 ) :32-37.
  • 8Hsieh MH, Pai W, Tseng HI, Yang SN, Lu CC, Chen HL. Par- enteral nutrition-associated cholestasis in premature babies: risk factors and predictors [ J ]. Pediatr Neonatol, 2009, 50 ( 5 ) : 202- 207.
  • 9Robinson DT, Ehrenkranz RA. Parenteral nutrition-associated cholestasis in small for gestational age infants [ J]. J Pediatr, 2008, 152(1) :59-62.
  • 10Costa S, Maggio L, Sindico P, Cota F, De Carolis MP, Romagnoli C. Preterm small for gestational age infants are not at high risk for parenteral nutrition-associated cholestasis [ J]. J Pediatr, 2010, 156(4) :575-579.

共引文献40

同被引文献78

引证文献10

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部